The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.65BCNY
246.09M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue (TTM)
275.80MCNY
41.01M · vs all stocks (USD)
Updated Aug 21, 2026
Profit Margin
-39.72%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Beta
0.9780x
vs all stocks
Updated Aug 21, 2026
52-Week Change
-16.74%
vs all stocks
Updated Aug 21, 2026
Market Capitalization
1.65BCNY
246.09M · vs all stocks (USD)
Updated Aug 21, 2026
Enterprise Value
1.65BCNY
245.69M · vs all stocks (USD)
Updated Aug 21, 2026
Price to Sales (TTM)
5.77x
vs Scientific & Technical Instruments peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 6×.Updated Aug 21, 2026
Price to Book (MRQ)
3.34x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Enterprise to Revenue
5.99x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Enterprise to EBITDA
-26.49x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Gross Margin
13.69%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Profit Margin
-39.72%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Operating Margin
-34.09%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Return on Assets (TTM)
-7.25%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Return on Equity (TTM)
-22.73%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Revenue (TTM)
275.80MCNY
41.01M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue per Share (TTM)
1.74CNYUpdated Aug 21, 2026
Quarterly Revenue Growth
10.30%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Gross Profit (TTM)
34.27MCNY
5.10M · vs all stocks (USD)
Updated Aug 21, 2026
EBITDA (TTM)
-62.37MCNY
-9.28M · vs all stocks (USD)
Updated Aug 21, 2026
Net Income (TTM)
-109.54MCNY
-16.29M · vs all stocks (USD)
Updated Aug 21, 2026
Quarterly Earnings Growth (YoY)
5.19%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Operating Cash Flow (TTM)
-20.73MCNY
-3.08M · vs all stocks (USD)
Updated Aug 21, 2026
Levered Free Cash Flow (TTM)
-28.10MCNY
-4.18M · vs all stocks (USD)
Updated Aug 21, 2026
Payout Ratio
0.00%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Minority Interest (Equity)
1.65MCNYFY2025 · Dec 31, 2025
Revenue
270.01MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
234.28MCNYFY2025 · Dec 31, 2025
Gross Profit
35.73MCNYFY2025 · Dec 31, 2025
Operating Income
-102.78MCNY
-15.29M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-109.93MCNYFY2025 · Dec 31, 2025
Income Tax Expense
5.86MCNYFY2025 · Dec 31, 2025
Net Income
-115.79MCNYFY2025 · Dec 31, 2025
EBIT
-104.28MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-57.11MCNYFY2025 · Dec 31, 2025
Research & Development
56.27MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
32.30MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
3.56MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
378.43KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
5.66MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.7300CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.7300CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
158.69MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
158.69MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-115.79MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-47.51KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-54.71MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-77.61MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
66.91MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-115.79MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
7.38MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
43.69MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
10.01MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-22.90MCNYFY2025 · Dec 31, 2025
Sale of Investments
28.72KCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-22.87MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
75.50MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-100.08MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-4.31MCNYFY2025 · Dec 31, 2025
Other Financing Charges
48.10MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
19.21MCNYFY2025 · Dec 31, 2025
Shares Outstanding
168.00MSharesUpdated Aug 21, 2026
Float Shares
46.99MSharesUpdated Aug 21, 2026
% Held by Insiders
66.64%
vs all stocks
Updated Aug 21, 2026
% Held by Institutions
2.42%
vs all stocks
Updated Aug 21, 2026
Total Cash (MRQ)
42.07MCNY
6.26M · vs all stocks (USD)
Updated Aug 21, 2026
Total Cash per Share (MRQ)
0.2680CNYUpdated Aug 21, 2026
Total Debt (MRQ)
145.25MCNY
21.60M · vs all stocks (USD)
Updated Aug 21, 2026
Total Debt to Equity (MRQ)
0.3252x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Current Ratio (MRQ)
1.13x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Book Value per Share (MRQ)
2.84CNYUpdated Aug 21, 2026
Total Assets
814.80MCNY
121.17M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
353.81MCNYFY2025 · Dec 31, 2025
Total Liabilities
356.70MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
460.99MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
63.23MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
293.47MCNYFY2025 · Dec 31, 2025
Cash
65.91MCNYFY2025 · Dec 31, 2025
Cash Equivalents
5.89MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
71.80MCNYFY2025 · Dec 31, 2025
Accounts Receivable
169.11MCNYFY2025 · Dec 31, 2025
Inventory
67.33MCNYFY2025 · Dec 31, 2025
Accounts Payable
154.04MCNYFY2025 · Dec 31, 2025
Short-term Debt
120.94MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
541.88KCNYFY2025 · Dec 31, 2025
Long-term Debt
26.09MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
168.00MCNYFY2025 · Dec 31, 2025
Retained Earnings
-128.28MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
458.09MCNY
68.12M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
62.89MCNYFY2025 · Dec 31, 2025
52-Week Low
7.26CNYUpdated Aug 21, 2026
52-Week High
14.58CNYUpdated Aug 21, 2026
52-Week Change
-16.74%
vs all stocks
Updated Aug 21, 2026
Beta
0.9780x
vs all stocks
Updated Aug 21, 2026
50-Day MA
9.18CNYUpdated Aug 21, 2026
200-Day MA
10.91CNYUpdated Aug 21, 2026
Avg 10-Day Volume
1.80MSharesUpdated Aug 21, 2026
Avg 30-Day Volume
2.05MSharesUpdated Aug 21, 2026
Diluted EPS (TTM)
-0.6900CNYUpdated Aug 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits well below its yearly mean, with net income and assets falling four years.
Reads
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 13.7%, lower than 95% of its Scientific & Technical Instruments peers (median 38.1%)Significant